Wholesale Gc Inlet Septa for Shimadzu Gc Injection 25PCS/Bottle

Name: Wholesale Gc Inlet Septa for Shimadzu Gc Injection 25PCS/Bottle
Brand: Zhejiang Aijiren Technology, Inc.
SKU: 1965442111

Zhejiang, ChinaZhejiang Aijiren Technology, Inc.

US$9.60

1-9 Bags

US$9.40

10+ Bags

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

Gc Inlet Instrument

Material

Rubber

Model NO.

GCS01

Usage

Gc Instrument Inlet Seal

Characteristic

Low-Bleed Septum

Max. Temp

350

Certification

ISO9001, Intertek

Injector

Easy to Puncture

Transport Package

25pieces/Pack

Specification

5.5*7*7.5mm

Trademark

Aijiren

Origin

Zhejiang, China

HS Code

70179000

Production Capacity

5000PCS/Day

Company profile

Zhejiang Aijiren Technology, Inc.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 19 Years CertifiedNearest Port: Ningbo Port, Shanghai PortAverage Response Time: ≤5.00h

AI-Powered supplier vetting

SummaryThe supplier is identified as a factory and limited company with 119 employees, offering HPLC vials, TOC and headspace vials, septa, syringe filters, and COD tubes. It reports broad customization, ODM capability, recent new-product development, and OEM service for well-known brands. Production information includes substantial stated annual volumes for several product categories, inventory capability, valid contracts with associated subcontractors, and seasonal lead times of within 15 working days off-season and one month during peak season. Service procedures, corrective actions, complaint handling, ISO certifications, ERP integration, and recent fire drills are documented. However, it has no overseas warehouse or showroom, no available SDK, and the provided information does not establish specific customer cases or fully substantiate financial strength.

Supplier typeThe supplier describes itself as a factory and a limited company, with 119 employees and no larger company-group affiliation. This supports classification as an independent manufacturing supplier rather than a trading-only entity.

CertificationsThe supplier reports ISO45001:2018, ISO9001:2015, and ISO14001 certifications. These explicitly indicate coverage of occupational health and safety, quality management, and environmental management systems.

After-Sales capabilityThe supplier has written procedures and records for service assessment, corrective and preventive actions, and customer complaint handling. It also reports inventory capability, but lacks an overseas warehouse and overseas showroom; therefore, documented service processes exist while overseas service infrastructure is limited.

R&D capabilityThe supplier reports new products during the past year, ODM services, and multiple customization modes. ERP-based digital management is also in use, but no SDK is available; the evidence supports product-development capability but not a complete technical-development ecosystem.

Production capacityThe supplier provides stated annual output volumes for syringe filters, autosampler vials, PTFE/silicone septa, and glass reagent bottles, reports inventory capability, and maintains contracts with associated subcontractors. It also states six qualified suppliers and lead times of within 15 working days off-season and one month during peak season, supporting established production capacity.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization. It also reports ODM service, indicating broad stated adaptation and design-manufacturing capability.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of brand-serving experience. However, no customer names, project descriptions, volumes, or verifiable case details are provided, so the depth of customer-case evidence remains limited.